[ Price : $8.95]
FDA releases a corrected version of a 12/30 Complete Response Letter issued to Corcept Therapeutics, indicating that the agency ha...[ Price : $8.95]
Ultragenyx Pharmaceutical resubmits a BLA seeking accelerated approval for UX111, an AAV9 gene therapy for the treatment of Sanfil...[ Price : $8.95]
Elevar Therapeutics files an NDA for lirafugratinib as a second-line treatment for patients with cholangiocarcinoma whose tumors h...[ Price : $8.95]
Sen. Rick Scott (R-FL) introduces legislation that would require prescription drug labels in the U.S. to disclose where drugs and ...[ Price : $8.95]
University of Southern California public policy professor Genevieve Kanter airs concerns about the impact of the many changes that...[ Price : $8.95]
FDA approves Tenpoint Therapeutics Yuvezzi as the only combination eye drop approved to treat presbyopia in adults.[ Price : $8.95]
FDA posts an updated guidance clarifying when clinical decision support software functions fall outside the definition of a regula...[ Price : $8.95]
An industry consultant says reduced FDA staffing levels and high turnover are extending regulatory timelines and forcing drug deve...